12Aug
11Aug
We tested canned wines and picked out these four as the best
Canned wine is having a moment right now: According to the Wine Industry Advisor, the market share of canned wine (in relation to the larger wine industry) went up during the pandemic, and experts projected that by 2025, canned wine will make up 10% of the market. Archer Roose isn’t one vineyard, but rather a company that features different varieties of wine from around the world. The rosé is a white wine made from 100% Greek Roditis grapes that’s made...
11Aug
Technology helps visually impaired pianist in Massachusetts see music, audience
The sound of music coming from a home in Salem hits all the right notes, but the musician has a difficult time seeing them.Fournier was diagnosed with severe visual impairment at age 3. "It’s the optic nerve that’s wrong. The eyes themselves, that can be replaced, but the optic nerve was never developed properly," he said. The device is on permanent loan from the Commission for the Blind, he received the eSight device in June. Read more >>
11Aug
You Now Have More Time to Repay Student Loans. Here’s How to Take Advantage of This ‘Fantastic Opportunity’
If you have federal student loan debt, you now have approximately six months to prepare for payments on that debt to restart. Last week, President Joe Biden’s administration announced it is stretching out the moratorium on federal student loan payments until Jan. 31, 2022. “What a fantastic opportunity for borrowers to take more control of their finances,” says Laurel Taylor, CEO and founder of FutureFuel.io, a student debt repayment platform. “It will be near two years of payment suspension as...
11Aug
New technology is helping visually impaired pianist see his sheet music and audience
Fournier was diagnosed with a severe visual impairment when he was 3. "It’s the optic nerve that’s wrong. The eyes themselves, that can be replaced, but the optic nerve was never developed properly," he said. For years, he used a pair of glasses that included a telescoping lens to help him read his modified sheet music, but that was of limited use. But new technology is offering Fournier "a whole new way of seeing." The device is on permanent loan...
11Aug
Boston Harbor Angels leads Xeno Biosciences $7.25M Series A Round
Somerville, MA, Aug 8, 2021 – Xeno Biosciences Inc., a clinical stage drug discovery and development company advancing therapeutics for the treatment of obesity and metabolic diseases, announced today the completion of the Company’s Series A financing, which raised $7.25M in a private round. The investment round was led by Boston Harbor Angels and was joined by a syndicate of individuals and groups including Clinical Research Ventures, Maine Angels, Bangor Angels, Dirigo Angels, Santa Barbara Angels, Beacon Angels, SideCar Angels, NOLA...
10Aug
Advice for Brand Leaders on Crafting Authentic Celebrity Collaborations
You know what they say, if it’s a day that ends in “y,” there’s a new celebrity liquor brand out. Well, maybe that’s not a saying, but nowadays, it should be. From Nick Jonas to Sammy Hagar to Post Malone to Kendall Jenner, the celebrity-branded liquor space gets more crowded by the day. Hollywood producer and actress Elizabeth Banks, for example, recently announced a partnership with a wine brand. More than just a brand ambassador, she, like Reynolds before her,...
10Aug
CytoAgents’ Phase 1 Trial Results Show “Cytokine Release Syndrome” Drug Candidate Safe
Successful Completion of Phase 1 Clinical Trial, Close of Initial Equity Round of Funding, and Addition of Dr. Stanley Marks and John Friedman to Board of Directors Positions CytoAgents for Larger Series A and Phase II Trials. Read more >>
06Aug
Akston Biosciences Doses First Subjects in Phase II Clinical Trial of Second-Generation Protein Subunit COVID-19 Vaccine
Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, announced today that the first participants have been dosed in a Phase II open-label trial of AKS-452, its protein subunit COVID-19 vaccine candidate. Fifty-two volunteers will receive either one- or two-dose regimens as part of the Phase II trial conducted at University Medical Center Groningen (UMCG), one of the largest hospitals in the Netherlands. Read more >>
06Aug